We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

IBN's Droplet Array Sheds Light on Drug-Resistant Cancer Stem Cells

Product News   May 09, 2012

 
IBN's Droplet Array Sheds Light on Drug-Resistant Cancer Stem Cells
FURTHER INFORMATION
 
 
 

Related Product News

TMAC Cancer Therapy Platform Demonstrates Successful Proof-of-concept

Product News

Avacta, the developer of Affimer® biotherapeutics and reagents, has announced that it has demonstrated initial proof-of-concept for its proprietary new class of drug conjugate.

READ MORE

Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture

Product News

Avacta and Daewoong Pharmaceutical have announced a collaboration to develop the next generation of cell and gene therapies incorporating Affimer proteins to enhance the immune-modulatory effects.

READ MORE

Collaborative to Fund Lung Cancer Immunotherapy Clinical Trial

Product News

Vaccitech has announced that it has entered into a clinical partnership with Cancer Research UK to develop a novel immunotherapy as a treatment option for patients with non-small cell lung cancer.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE